All Updates

All Updates

icon
Filter
Product updates
Intel launches new AI chip Gaudi 3 to be commercially available from Q3
Generative AI Infrastructure
Apr 9, 2024
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Dec 20, 2024
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Funding
Partnerships
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Generative AI Infrastructure

Generative AI Infrastructure

Apr 9, 2024

Intel launches new AI chip Gaudi 3 to be commercially available from Q3

Product updates

  • Intel has launched its latest AI chip, Gaudi 3, designed to enhance the training and deployment of complex AI models like those used by OpenAI's ChatGPT. It will be commercially available to customers in the third quarter. However, pricing details are yet to be specified.

  • The Intel Gaudi 3 AI will power AI systems with up to tens of thousands of accelerators, and the company claims its chip outperforms Nvidia's H100 GPUs.

  • The new chips are part of Intel's effort to fulfill enterprise-specific ML and GenAI requirements and address scaling challenges faced by enterprises.

  • Analyst QuickTake: With the Gaudi 3 chip, Intel aims to disrupt and capture a significant portion of the rapidly expanding AI chip market, which is currently dominated by Nvidia, holding approximately 80% of the market share. Moreover, late last month, Intel and the US Department of Commerce signed a non-binding preliminary memorandum of terms (PMT) for up to USD 8.5 billion in direct funding to Intel for commercial semiconductor projects under the CHIPS and Science Act.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.